Literature DB >> 11918469

Progressive myoclonic epilepsies.

Joan A Conry1.   

Abstract

The progressive myoclonic epilepsies are a rare but extremely debilitating group of disorders that are difficult to diagnose and even harder to treat. They represent a heterogeneous subgroup of those with secondary generalized epilepsy. Efficacy of treatment is often measured in terms of slowing a patient's inevitable decline. Reviewed here are the classification of progressive myoclonic epilepsies, features of myoclonic seizures, the five most prevalent progressive myoclonic epilepsy syndromes-Unverricht-Lundborg disease, myoclonus epilepsy with ragged red fibers (MERRF) mitochondrial disease, Lafora's disease, neuronal ceroid lipofuscinoses, and sialidoses-and current treatment options.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918469     DOI: 10.1177/08830738020170011201

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

Review 1.  Application of Anticonvulsants, Antiepileptic Drugs, and Vitamin C in the Treatment and Analysis of Batten Disease.

Authors:  Shreya Reddy; Hetal Brahmbhatt
Journal:  Cureus       Date:  2022-01-30

2.  Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation.

Authors:  Anil V Israni; Anirban Mandal
Journal:  J Pediatr Neurosci       Date:  2018 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.